Indefinite Delivery Contract SPE2DU25D9531

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The $499,999,999 single-award IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards. The contract supports the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet.